Mefecod contains 50mg of Butamirate Citrate in a sustained-release tablet, offering long-lasting relief from dry, irritating coughs. As a non-opioid antitussive, it acts centrally on the cough center in the brain to suppress the cough reflex without the risk of dependency or common sedative side effects associated with other cough medications.
The sustained-release (SR) formulation is specifically designed to release the active ingredient gradually over several hours, ensuring you stay cough-free throughout the day or night with fewer doses.
Key Benefits:
-
Non-Drowsy Formula: Provides effective cough suppression without causing significant sleepiness, making it ideal for daytime use.
-
Sustained-Release Technology: Offers extended relief, reducing the frequency of dosing (typically taken only 2-3 times daily).
-
Broad Indication: Effective for the symptomatic treatment of coughs of various origins, including dry cough associated with colds, flu, and respiratory tract infections.
-
Sugar-Free Option: Generally suitable for patients who need to monitor their sugar intake compared to cough syrups.
Dosage and Administration: Adults: Take one (1) tablet 2 or 3 times daily, or as directed by a healthcare professional. Swallow the tablet whole; do not crush or chew to maintain the sustained-release property.





